Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. (Q47367539)

http://europepmc.org/abstract/MED/29205868

14 January 2018

title

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. (English)

1 reference

http://europepmc.org/abstract/MED/29205868

14 January 2018

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Daniela Drandi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Gian Maria Zaccaria

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Claudio Agostinelli

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Marco Ladetto

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Simone Ferrero

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

author name string

D Barbero

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

I Dogliotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

B Mantoan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M Gambella

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

L Monitillo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

I Della Starza

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

M Cavalli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

L A De Novi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

E Ciabatti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

S Grassi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

A Gazzola

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

C Mannu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

I Del Giudice

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

S Galimberti

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

P P Piccaluga

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

Fondazione Italiana Linfomi (FIL) MRD Network

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

publication date

4 December 2017

1 reference

http://europepmc.org/abstract/MED/29205868

14 January 2018

published in

International Journal of Laboratory Hematology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

page(s)

201-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

Assuring the quality of next-generation sequencing in clinical laboratory practice

11 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Long-term results of the GIMEMA VEL-03-096 trial in MM patients receiving VTD consolidation after ASCT: MRD kinetics' impact on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

MRD detection in B-cell non-Hodgkin lymphomas using Ig gene rearrangements and chromosomal translocations as targets for real-time quantitative PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Red blood cell depletion from bone marrow and peripheral blood buffy coat: a comparison of two new and three established technologies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

IMGT, the international ImMunoGeneTics information system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FIJLH.12766

21 January 2018

Identifiers

DOI

10.1111/IJLH.12766

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29205868%20AND%20SRC:MED&resulttype=core&format=json

11 June 2020

1 reference